The European Union Agencies Network on Scientific Advice (EU-ANSA) has reaffirmed the central role of EU agencies in supporting research and translating scientific knowledge into evidence-based policymaking, through a Joint statement signed by the Chief Scientists or highest-ranking scientific officers of member agencies.
Drawing on experience from recent crises, such as COVID-19, EU-ANSA highlights how EU agencies contribute across the research knowledge cycle – from identifying policy-relevant knowledge gaps and shaping research priorities, to supporting the uptake of research results in…
Čtěte více
The European Commission has taken a major step to introduce EU-wide controls on nine high-risk precursor chemicals used in illicit drug production via new legislation published this week. The Delegated Regulation (EU) 2026/314 (1) builds on the findings of the first EU-level precursor assessments carried out by the European Union Drugs Agency (EUDA) in 2025 (see news item).
Eight of the precursors in question are linked to the production of four synthetic cathinones (3-CMC, 3-MMC, 4-CMC, 4-MMC), while one substance (phenyl-2-nitropropene) is used in amphetamine production.
The regulation…
Čtěte více
New substances, new markets, new risks — understanding Europe’s changing drug landscape starts with solid facts. On 9 June, the European Union Drugs Agency (EUDA) will launch the European Drug Report 2026: Trends and Developments in Brussels, delivering the latest evidence on the state of the drugs problem in Europe. Drawing on data from 29 countries (EU-27, Norway and Türkiye), the comprehensive analysis covers drug use and supply as well as drug-related harms and responses.
The online report features over 100 graphics, including interactive dashboards, allowing readers to visualise data…
Čtěte více
